Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
7.05
-0.10
(-1.40%)
At close: February 28 at 4:25:36 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 2 | 8 | 8 |
| Avg. Estimate | 3.41M | 1.7M | 8.04M | 5.76M |
| Low Estimate | 3.41M | -- | -- | -- |
| High Estimate | 3.41M | 3.41M | 13.63M | 14.2M |
| Year Ago Sales | -- | -- | 4.6M | 8.04M |
| Sales Growth (year/est) | -- | -- | 74.72% | -28.28% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2X10.SG | -- | -- | -- | -- |
| S&P 500 | 16.00% | 7.22% | 10.60% | 14.10% |
Upgrades & Downgrades
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 1/10/2025 |
| Initiated | JMP Securities: Market Outperform | 12/4/2024 |
| Initiated | Laidlaw & Co.: Buy | 7/29/2024 |
| Initiated | BTIG: Buy | 5/20/2024 |
| Initiated | Guggenheim: Buy | 4/29/2024 |
| Initiated | Piper Sandler: Overweight | 4/29/2024 |
Related Tickers
25I.F ImmuPharma plc
0.0265
-37.65%
SANNz.XC
0EVI.IL Innate Pharma S.A.
2.1375
-3.93%
VTRO
KAPA Kairos Pharma, Ltd.
1.1900
-1.65%
AFMD Affimed N.V.
1.0300
-0.96%
MBX MBX Biosciences, Inc.
9.60
-2.24%
ZBIO Zenas BioPharma, Inc.
7.01
+6.05%
BCAX Bicara Therapeutics Inc.
13.30
+7.61%
CSBR Champions Oncology, Inc.
10.28
+0.59%